Xcout IntelSign inSubscribe

Ferrer competitors & alternatives

PharmaceuticalsSpain

The 12 closest competitors and alternatives to Ferrer among pharmaceuticals companies — ranked by similarity to what Ferrer actually does, not by market-cap band.

12Competitors listed

Subscribe to see Ferrer’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Ferrer

Ferrer is a company founded in Barcelona, Spain, in 1959, with its headquarters on Avenida Diagonal. The company has a presence in multiple locations and employs 1,692 people. Ferrer aims to use business to fight for social justice and offers medication in its field.

Ferrer at a glance

Ferrer is a pharmaceuticals company headquartered in Spain. Xcout tracks 15 named people at Ferrer, including Mario Rovirosa (CEO).

Ferrer leadership

  • Mario RovirosaCEO
  • Sergi Ferrer-SalatPresident
  • Beatriz VilaChief People & Culture Officer
  • Cecilia von AhnChief Transformation Officer
  • David FerrandoChief Marketing & Market Access Officer
  • David FerrerChief Financial & Corporate Services Officer

9 more named people on record for Ferrer, with roles, board committees and tenure — see the full roster →

Top 12 Ferrer competitors

Ranked by semantic similarity — how close each company is to Ferrer by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

GrifolsGRFS · PharmaceuticalsBarcelona, Spain
63% matchPublic

Similar pharmaceuticals company

Grifols, S.A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions. The Bioscience division is dedicated to researching, producing, and marketing plasma-derived medicines, such as immunoglobulins, alpha-1 antitrypsin, albumin, and clotting factors, along with other innovative treatments for chronic, rare, prevalent, and life-threatening conditions. The Hospital division provides non-biological pharmaceuticals, medical supplies, clinical nutrition solutions, intravenous therapies, and medical devices. The Diagnostic division develops, manufactures, and commercializes diagnostic products that span the entire healthcare continuum, from prevention and screening to diagnosis, prognosis, and monitoring of diseases and treatments, catering to professional healthcare providers. The Bio Supplies division offers essential biological materials for life-science research, clinical trials, and the manufacturing of pharmaceutical and diagnostic products. These diverse offerings enable healthcare professionals to diagnose and treat patients suffering from conditions like hemophilia, immune deficiencies, and infectious diseases. Grifols serves a wide array of clients, including public and private healthcare organizations, wholesalers, distributors, group purchasing organizations, blood banks, hospitals, and national health systems. The company also maintains a technology collaboration agreement with Mondragon.

Market cap$4.9B
Employees23,833
Grifols competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Ferrer and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Ferrerand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →